GT729 Universal Cell Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GT729 Universal Cell Injection, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD) [EARLY_Phase 1]